| Breakdown | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 392.40M | 394.62M | 420.11M | 431.84M | 400.01M |
| Gross Profit | 120.41M | 117.29M | 125.34M | 131.05M | 114.72M |
| EBITDA | 69.80M | 68.48M | 74.02M | 77.61M | 60.73M |
| Net Income | 42.63M | 40.22M | 42.60M | 47.30M | 28.98M |
Balance Sheet | |||||
| Total Assets | 363.20M | 348.94M | 399.19M | 393.83M | 368.84M |
| Cash, Cash Equivalents and Short-Term Investments | 34.57M | 72.47M | 110.92M | 93.97M | 85.61M |
| Total Debt | 9.21M | 9.48M | 9.57M | 13.01M | 15.33M |
| Total Liabilities | 54.47M | 46.95M | 49.35M | 62.40M | 65.03M |
| Stockholders Equity | 308.73M | 301.98M | 349.84M | 331.43M | 303.81M |
Cash Flow | |||||
| Free Cash Flow | 0.00 | 59.97M | 62.57M | 42.44M | 44.14M |
| Operating Cash Flow | 52.73M | 65.86M | 69.07M | 46.78M | 50.68M |
| Investing Cash Flow | -44.85M | 13.20M | -54.99M | -11.46M | -10.05M |
| Financing Cash Flow | -40.31M | -93.65M | -26.45M | -26.96M | -30.21M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $522.80M | 12.68 | 13.44% | 5.53% | -0.56% | 7.80% | |
71 Outperform | $372.72M | 3.58 | 11.26% | 8.17% | -4.54% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | $12.51B | 19.77 | 30.81% | 2.04% | 2.89% | 1.99% | |
55 Neutral | $503.29M | -2.56 | -9.00% | ― | -10.18% | -46.06% | |
54 Neutral | $938.94M | -4.81 | -46.27% | 20.53% | 7.52% | -1.67% |